Abstract
The tumor suppressor p53 protein is known to play a critical role in apoptosis. In normal human diploid fibroblasts (HDFs), expression of the human papillomaviral (HPV) E6 gene results in a reduction of p53 protein and an inhibition of oxidant induced apoptosis within 24˜h. In comparison, expression of the HPV E7 gene causes down-regulation of Rb protein without inhibiting apoptosis. Here we determine whether HDFs expressing E6 undergo cell death with a delayed time course following H2O2exposure. Appearances of caspase-3 activity, cell detachment, trypan blue uptake and aberrant nuclei were all delayed in E6 cells compared to wild type (wt) or E7 cells. A mutant E6 gene that failed to reduce p53 could not delay cell death. Morphological examination revealed nuclear condensation in dying wt or E7 cells but nuclear fragmentation in E6 cells. Flow cytometry analysis indicated an S˜phase distribution of dying wt or E7 cells but a G2/M phase distribution of dying E6 cells. An elevation of cyclin B was observed in dying E6 cells but not in apoptotic E7 cells. Dying E6 cells also had elevated levels of cdc-2 protein and histone kinase activity, suggesting that the cells died at mitosis. Electron microscopy studies showed that E6 cells may die at prophase or prometaphase. Overexpression of bcl-2 resulted in an inhibition of both caspase-3 and death of E7 or E6 cells. Inactivating caspases with zVAD-fmk also reduced the death rate of E7 and E6 cells. Our data indicate that expression of HPV E6 causes a delay and morphological modification of cell death induced by oxidants. E6 cells die at mitosis, which can be inhibited by bcl-2 overexpression or caspase inhibition.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adams JM, Cory S . 1998 Science 281: 1322–1326
Chao DT, Korsmeyer SJ . 1998 Ann. Rev. Immunol. 16: 395–419
Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE . 1997 Science 276: 1425–1428
Chen QM, Bartholomew JC, Campisi J, Acosta M, Reagan JD, Ames BN . 1998 Biochem. J. 332: 43–50
Chen QM, Liu J, Merrett J . 2000a Biochem. J. 347: 543–551
Chen QM, Tu VC, Catania J, Burton M, Toussaint O, Dilley T . 2000b J. Cell Sci. 113: 4087–4097
Clarke DJ, Gimenez-Abian JF . 2000 Bioessays 22: 351–363
Dalal S, Gao Q, Androphy EJ, Band V . 1996 J. Virol. 70: 683–688
Ding HF, McGill G, Rowan S, Schmaltz C, Shimamura A, Fisher DE . 1998 J. Biol. Chem. 273: 28378–28383
Earnshaw WC, Pluta AF . 1994 Bioessays 16: 639–643
Endlich B, Radford IR, Forrester HB, Dewey WC . 2000 Radiation Res. 153: 36–48
Frisch SM, Vuori K, Delaita D, Sicks S . 1996 J. Cell Biol. 135: 1377–1382
Green DR, Reed JC . 1998 Science 281: 1309–1312
Halbert CL, Demers GW, Galloway DA . 1991 J. Virol. 65: 473–478
Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne VL, Culhane AC, Williams GT . 1996 Eur. J. Biochem. 236: 1–26
Huang C, Zhang Z, Ding M, Li J, Ye J, Leonard SS, Shen HM, Butterworth L, Lu Y, Costa M, Rojanasakul Y, Castranova V, Vallyathan V, Shi X . 2000a J. Biol. Chem. 275: 32516–32522
Huang S, Huang CF, Lee T . 2000b Biochem. Pharmacol. 60: 771–780
Lee JM . 1998 Oncogene 17: 1653–1662
Levin S, Bucci TJ, Cohen SM, Fix AS, Hardisty JF, LeGrand EK, Maronpot RR, Trump BF . 1999 Toxicol. Pathol. 27: 484–490
Li PF, Dietz R, von Harsdorf R . 1999 EMBO J. 18: 6027–6036
Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T . 1993 Nature 362: 847–849
Majno G, Joris I . 1995 Am. J. Pathol. 146: 3–15
Meredith J, Schwartz M . 1997 Trends Cell Biol. 7: 146–150
Moll UM, Zaika A . 2001 FEBS Lett. 493: 65–69
Morgan DO . 1997 Ann. Rev. Cell Dev. Biol. 13: 261–291
Ohi R, Gould KL . 1999 Curr. Opin. Cell Biol. 11: 267–273
Pines J . 1995 Biochem. J. 308: 697–711
Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B . 1997 Nature 389: 300–305
Quillet-Mary A, Jaffrezou JP, Mansat V, Bordier C, Naval J, Laurent G . 1997 J. Biol. Chem. 272: 21388–21395
Reed JC . 1997 Nature 387: 773–776
Ruoslahti E, Reed JC . 1994 Cell 77: 477–478
Russell P . 1998 Trends Biochem. Sci. 23: 399–402
Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P, Green DR . 2000 J. Biol. 275: 7337–7342
Sheikh MS, Fornace Jr AJ . 2000 J. Cell Biol. Physiol. 182: 171–181
Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW, Greenberg AH . 1994 Science 263: 1143–1145
Stridh H, Kimland M, Jones DP, Orrenius S, Hampton MB . 1998 FEBS Lett. 429: 351–355
Tada-Oikawa S, Oikawa S, Kawanishi M, Yamada M, Kawanishi S . 1999 FEBS Lett. 442: 65–69
Thompson CB . 1995 Science 267: 1456–1462
Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X . 1997 Science 275: 1129–1132
Zachariae W . 1999 Curr. Opin. Cell Biol. 11: 708–716
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, Q., Merrett, J., Dilley, T. et al. Down regulation of p53 with HPV E6 delays and modifies cell death in oxidant response of human diploid fibroblasts: an apoptosis-like cell death associated with mitosis. Oncogene 21, 5313–5324 (2002). https://doi.org/10.1038/sj.onc.1205644
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.onc.1205644
Keywords
This article is cited by
-
Mechanism of cell death resulting from DNA interstrand cross-linking in mammalian cells
Cell Death & Disease (2011)


